COMPASS THERAPEUTICS, INC. Earnings Per Share (Basic)
COMPASS THERAPEUTICS, INC. (CMPX) reported Earnings Per Share (Basic) of -$0.13 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- COMPASS THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.13.
- COMPASS THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.10.
- COMPASS THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.08.
- COMPASS THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.08.
- COMPASS THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$0.42.
- COMPASS THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$0.36.
- COMPASS THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$0.33.
- COMPASS THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$0.37.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.13 10-Q · filed 2026-08-06 | -$0.23 10-Q · filed 2026-08-06 | -$0.32 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2026-03-31 | -$0.10 10-Q · filed 2026-05-05 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-12-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.42 10-K · filed 2026-03-05 |
| 2025-09-30 | -$0.08 10-Q · filed 2025-11-05 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.34 10-Q · filed 2025-11-05 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-06-30 | -$0.14 10-Q · filed 2026-08-06 | -$0.26 10-Q · filed 2026-08-06 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-03-31 | -$0.12 10-Q · filed 2026-05-05 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2024-12-31 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.19 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.36 10-K · filed 2026-03-05 |
| 2024-09-30 | -$0.08 10-Q · filed 2025-11-05 | -$0.17 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$0.25 10-Q · filed 2025-11-05 | -$0.35 derived: net income ÷ weighted average shares · filed 2025-11-05 |
| 2024-06-30 | -$0.10 10-Q · filed 2025-08-11 | -$0.17 10-Q · filed 2025-08-11 | -$0.28 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$0.36 derived: net income ÷ weighted average shares · filed 2025-11-05 |
| 2024-03-31 | -$0.08 10-Q · filed 2025-05-08 | -$0.18 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$0.26 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$0.35 derived: net income ÷ weighted average shares · filed 2025-11-05 |
| 2023-12-31 | -$0.11 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$0.18 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$0.27 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$0.33 10-K · filed 2025-02-27 |
| 2023-09-30 | -$0.08 10-Q · filed 2024-11-12 | -$0.17 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.23 10-Q · filed 2024-11-12 | -$0.33 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-06-30 | -$0.09 10-Q · filed 2024-08-12 | -$0.15 10-Q · filed 2024-08-12 | -$0.25 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.36 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-03-31 | -$0.06 10-Q · filed 2024-05-13 | -$0.16 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.27 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.36 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2022-12-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$0.22 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$0.30 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$0.37 10-K · filed 2024-03-21 |
| 2022-09-30 | -$0.12 10-Q · filed 2023-11-09 | -$0.20 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$0.27 10-Q · filed 2023-11-09 | -$0.42 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-06-30 | -$0.08 10-Q · filed 2023-08-03 | -$0.16 10-Q · filed 2023-08-03 | -$0.30 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$0.40 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-03-31 | -$0.07 10-Q · filed 2023-05-04 | -$0.22 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$0.31 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.09 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2021-12-31 | -$0.15 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$0.26 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$1.12 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$1.31 10-K · filed 2023-03-15 |
| 2021-09-30 | -$0.10 10-Q · filed 2022-11-09 | -$1.09 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$1.26 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$1.07 10-Q · filed 2022-08-01 | -$1.23 10-Q · filed 2022-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |